Table 4.
Adjudicated diagnosis | Criteria | |||||
---|---|---|---|---|---|---|
Zile 2001 | ESC 2007 | ESC 2016 | ||||
HF‐PEF (Group III) | No HF‐PEF (Group I, II, IV, or V) | HF‐PEF (Group III) | No HF‐PEF (Group I, II, IV, or V) | HF‐PEF (Group III) | No HF‐PEF (Group I, II, IV, or V) | |
HF‐PEF | 79 | 91 | 74 | 96 | 88 | 82 |
No HF‐PEF | 30 | 365 | 25 | 370 | 43 | 352 |
LR+ | 6.1 | 6.9 | 4.8 | |||
LR− | 0.58 | 0.60 | 0.42 | |||
Sensitivity | 46.5% (39.0–54.0) | 43.5% (36.0–51.3) | 51.8% (44.0–59.5) | |||
Specificity | 92.4% (89.8–95.0) | 93.7% (91.3–96.1) | 89.1% (85.6–92.0) |
ESC, European Society of Cardiology; HF‐PEF, heart failure with preserved ejection fraction; HF‐REF, heart failure with reduced ejection fraction; LR, likelihood ratio.